Journal profile · Genetics & Heredity
Genetics in Medicine
ISSN 1098-3600 · eISSN 1530-0366 · ELSEVIER · USA · Monthly · Founded 1998
Genetics in Medicine: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 6.1; hybrid open access; APC about USD 5,110; median 231 days to acceptance (118 articles, last 24 months); community-reported acceptance: fairly easy (Elsevier website: 26%); 221 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Genetics in Medicine is published by ELSEVIER and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Genomics and Rare Diseases, BRCA gene mutations in cancer and Genomic variations and chromosomal abnormalities, together about 44.1% of its articles. Its main subfields are Genetics. (generated from OpenAlex topic counts and CAS ranking data)
Genetics in Medicine (GIM) is an official journal of the American College of Medical Genetics and Genomics. The journal's mission is to enhance the knowledge, understanding, and practice of medical genetics and genomics through publications in clinical and laboratory genetics and genomics, including ethical, legal, and social issues as well as public health. As genetics and genomics continue to increase in importance and relevance in medical practice, the journal is an accessible and authoritative resource for the dissemination of medical genetic knowledge to all medical providers through appropriate original research, reviews, commentaries, standards, and guidelines. GIM encourages research that combats racism, includes diverse populations and is written by authors from diverse and underrepresented backgrounds.In addition:GIM does not publish case reportsManuscripts reporting population level research carried out in predominantly or exclusively White populations will generally not be accepted without strong justification for lack of diversity in the population studied.The significance of articles reporting data and/or observations from a limited geographic region is evaluated in the context of whether they are generalizable across relevant populations or whether they might fill a knowledge gap in populations that are underrepresented in genetics research or that experience health disparities.Although cancer genetics is a focus, GIM discourages cancer genetics manuscripts with data limited to somatic and/or tumor genetics. Manuscripts with novel findings on non-germline genetics (for example, somatic [tumor] variation, CHIP [clonal hematopoiesis of indeterminate potential], somatic and constitutional mosaicism) that inform our understanding of germline risk may also be considered. Manuscripts reporting on circulating tumor DNA (ctDNA) or "liquid biopsy" are also generally not within the scope of GIM.Manuscripts should not contain previously published material without appropriate permission.GWAS studies are generally low priority for GIM.
From the journal's Aims & Scope
Research area (LetPub): Genetics & Heredity
Editor-in-chief Robert D. SteinerPublisher website
Editorial board by country: none in mainland China; most named United States 37, Israel 4, Saudi Arabia 3, United Kingdom 2 (46 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Genomics and Rare DiseasesBiochemistry, Genetics and Molecular Biology21.3%
- BRCA gene mutations in cancerBiochemistry, Genetics and Molecular Biology16.3%
- Genomic variations and chromosomal abnormalitiesBiochemistry, Genetics and Molecular Biology6.6%
- Prenatal Screening and DiagnosticsMedicine6.1%
- Metabolism and Genetic DisordersBiochemistry, Genetics and Molecular Biology4.2%
- Genetic Associations and EpidemiologyBiochemistry, Genetics and Molecular Biology3.9%
- Genetic factors in colorectal cancerMedicine3.8%
- Ethics in Clinical ResearchMedicine3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Genetics & Heredity | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Genetics & Heredity | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Genetics & Heredity | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 6.1LetPub ·
- Impact factor (publisher)
- 6.2Publisher website ·
- CiteScore 2026-06
- 11.2LetPub ·
- CiteScore (publisher)
- 11.2Publisher website ·
- SJR 2026-06
- 2.69LetPub ·
- SNIP 2026-06
- 2.2LetPub ·
- h-index
- 111LetPub ·
- h-index
- 208OpenAlex ·
- i10-index
- 3,257OpenAlex ·
- 2-year mean citedness
- 4.29OpenAlex ·
- Self-citation rate
- 6.5%LetPub ·
- Share of gold OA articles
- 28.78%LetPub ·
Volume
- Articles per year
- 171LetPub ·
Articles by year OpenAlex count · 6,284 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 181 | 100 | 105 |
| 2025 | 221 | 183 | 871 |
| 2024 | 212 | 209 | 1,656 |
| 2023 | 209 | 209 | 3,435 |
| 2022 | 835 | 835 | 6,678 |
| 2021 | 353 | 352 | 12,247 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
231 daysMedian, submission to acceptance · P25–P75 193 days – 300 days
- Acceptance to online
- median 8 days (116 articles)
- Submission to online
- median 244 days
- Sample
- 118 articles with submission and acceptance dates (425 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- 26%LetPub ·
- Acceptance rate (publisher)
- 15%Publisher website ·
- Submission to first decision
- 3 daysPublisher website ·
- Submission to acceptance
- 166 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 5,110 / EUR 4,780 / GBP 4,090 / JPY 633,790 | — | — | |
| Publisher website | USD 5,500 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 200 words
- Reference style
- AMA
- Graphical abstract
- Optional
- Not considered
- Mendelian randomization; gene discovery for infertility; GWAS; case reports
Article types accepted1
- case reportGenetics in Medicine rarely publishes case reports or reports of gene-disease associations in a single patient/family or a very small cohort even if the experim…Length not stated
Policy excerpts from the journal's websiteAuthorship, Code availability, Conflicts of interest, Publication ethics, Open access, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
- Authorship Authorship Disputes
The journal, its staff and board members, do not get involved in authorship disputes. During the peer review process if there is disagreement among the authors about any aspect of authorship, then the journal reserves the right to halt the peer review and/or publication process while the authors resolve the disagreement. If after publication the journal is informed of irregularities in the authors…
Source ↗Publisher website ·- Code availability Data and code availability
GIM requires data sharing, without embargo, except for the very specific exceptions described below, and requires that published manuscripts include a statement of data and code availability. For examples of Data and Code Availability Statements, see published articles here: https://www.gimjournal.org/inpress.Authors are strongly encouraged to deposit their data in a suitable repository. In some c…
Source ↗Publisher website ·- Conflicts of interest Disclosure instructions
Authors must disclose the use of generative AI and AI-assisted technologies in the writing process by adding a statement at the end of their manuscript in the core manuscript file, before the References list. The statement should be placed in a new section entitled 'Declaration of AI and AI-assisted technologies in the writing process'. Statement: During the preparation of this work the author(s) …
Source ↗Publisher website ·- Publication ethics Genetics in Medicine Misconduct Policy
All queries should be directed to the Managing Editor (ME) Diane Dunham Drexler, MEd at ddrexler@acmg.net. In the event a complaint is against Diane Dunham Drexler please contact Kyle Brothers, MD, PhD, Chair, Ethics Advisory Committee, at kyle.brothers@louisville.edu.All complaints against the journal editors, reviewers, authors or staff are handled in strict confidence. The ME will bring the com…
Source ↗Publisher website ·- Open access Open Access
Article Publishing Charge (APC): USD 5,500 (excluding taxes). The amount you pay may be reduced during submission if applicable.Review this journal’s open access policy.
Source ↗Publisher website ·- Peer review Peer review
This journal operates a single anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…
Source ↗Publisher website ·- Plagiarism Plagiarism detection
ACMG journals’ policy on duplicate publications and submissionsManuscripts submitted to Genetics in Medicine or Genetics in Medicine Open must be based on original research and not published or concurrently submitted for publication elsewhere. Intentionally submitting or re-submitting work for duplicate publication is considered a breach of publishing ethics. For additional guidance, read about Mu…
Source ↗Publisher website ·- Preprints Preprints
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information). If your manuscript has been shared as a preprint please disclose this at the time of submission, or during the review process if this is…
Source ↗Publisher website ·- Trial registration / reporting guidelines Reporting guidelines
NLM Research Reporting Guidelines and Initiatives and EQUATOR list many guidelines to promote high quality of published research. The editors at GIM are encouraging authors to seek out appropriate guidelines for their studies, to fill in checklists if available, upload those checklists with your manuscript at submission, and to detail in the cover letter what guidelines were followed in producing …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- ELSEVIER
- Country or region
- USA
- Language
- English
- Frequency
- Monthly
- Founded
- 1998
- ISSN
- 1098-3600
- Electronic ISSN
- 1530-0366
- Society / sponsor
- American College of Medical Genetics and Genomics
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Genetics in Medicine
What CAS zone is Genetics in Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Genetics in Medicine is in Zone 1 of Medicine, and in Zone 1 of the minor category Genetics & Heredity; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Genetics in Medicine?
The latest impact factor listed by LetPub is 6.1; CiteScore 11.2, h-index 208.
How long does peer review take at Genetics in Medicine?
Based on the dates recorded on 118 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 231 days (interquartile range 193–300 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Fairly easy (Elsevier website: 26%)”; the journal's website gives an acceptance rate of 15%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Genetics in Medicine?
According to the journal's author guidelines: Abstract: ≤ 200 words; Reference style: AMA; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Genetics in Medicine based?
Of the 46 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (37), Israel (4) and Saudi Arabia (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Genetics in Medicine?
According to LetPub and DOAJ records, Genetics in Medicine is indexed in SCIE and Scopus. The journal's website also lists PubMed; that list has not been checked against each database.
Is Genetics in Medicine open access, and what is the APC?
Genetics in Medicine is a hybrid journal. For open-access publication: APC about USD 5,110.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .